Renovaro Biosciences Inc. (RENB)
NASDAQ: RENB · IEX Real-Time Price · USD
1.350
-0.050 (-3.57%)
At close: Jul 19, 2024, 12:00 AM
1.340
-0.010 (-0.74%)
Pre-market: Jul 22, 2024, 8:38 AM EDT
Renovaro Biosciences Employees
Renovaro Biosciences had 12 employees as of June 30, 2023. The number of employees decreased by 10 or -45.45% compared to the previous year.
Employees
12
Change (1Y)
-10
Growth (1Y)
-45.45%
Revenue / Employee
n/a
Profits / Employee
-$4,493,901
Market Cap
199.13M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| P3 Health Partners | 400 |
| bluebird bio | 323 |
| Personalis | 225 |
| Biodesix | 217 |
| CVRx, Inc. | 200 |
| Generation Bio Co. | 174 |
| ClearPoint Neuro | 107 |
| Trevi Therapeutics | 25 |
RENB News
- 5 weeks ago - Renovaro, Inc. Announces $10 million in Equity Committed - GlobeNewsWire
- 2 months ago - Renovaro Inc. and Amsterdam UMC Cancer Center Poised to Advance Cancer Immunotherapy - GlobeNewsWire
- 2 months ago - Top 5 Health Care Stocks Which Could Rescue Your Portfolio This Month - Renovaro (NASDAQ:RENB) - Benzinga
- 2 months ago - Transforming Cancer Detection: RenovaroCube Introduces Flamingo, a novel AI model based on Fragmentomics - GlobeNewsWire
- 3 months ago - RenovaroCube to Acquire 100% Ownership of Cyclomics, Reinforcing Cutting-Edge Cancer Diagnostics Partnership - GlobeNewsWire
- 3 months ago - Renovaro Inc. Proudly Announces the Appointment Of Professor Dr. Geert Kazemier as the Chairman of its Scientific Advisory Board, A Move That Heralds a New Era of Innovation and Progress in its Mission to Reshape Cancer Screening, Diagnosis, and Patient C - GlobeNewsWire
- 4 months ago - SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Renovaro Biosciences Inc. - RENB - PRNewsWire
- 5 months ago - ROSEN, LEADING INVESTOR COUNSEL, Encourages Renovaro Biosciences Inc. Investors to Inquire About Securities Class Action Investigation - RENB - PRNewsWire